2022
Nanoparticle-based drug delivery for the treatment of traumatic brain injury
Mohammed F, Omay S, Sheth K, Zhou J. Nanoparticle-based drug delivery for the treatment of traumatic brain injury. Expert Opinion On Drug Delivery 2022, 20: 55-73. PMID: 36420918, PMCID: PMC9983310, DOI: 10.1080/17425247.2023.2152001.Peer-Reviewed Original ResearchConceptsTraumatic brain injuryBrain injurySecondary outcomesClinical trialsPathophysiology of TBIPhase III clinical trialsPhase II clinical trialClinical management strategiesSite of injuryOff-target toxicityPharmacological treatmentBrain penetrationLow off-target toxicityExperimental animalsInjuryChronic timescalesDosage thresholdDrug deliveryTrialsDrug targetingOutcomesTreatmentDeliveryPathophysiology
2012
Decompressive hemicraniectomy for ischemic stroke in the pediatric population
Omay SB, Carrión-Grant GM, Kuzmik GA, Fu M, Grant R, Schindler JL, Diluna ML, Duncan CC, Bulsara KR. Decompressive hemicraniectomy for ischemic stroke in the pediatric population. Neurosurgical Review 2012, 36: 21-25. PMID: 22886322, DOI: 10.1007/s10143-012-0411-4.Peer-Reviewed Original ResearchConceptsDecompressive hemicraniectomyPediatric populationAdult patientsSpace-occupying hemispheric infarctionMaximal medical therapyMalignant strokeHemispheric infarctionIschemic strokeSymptom onsetMedical therapyPediatric patientsPoor prognosisTreatment optionsPediatric literatureFatality ratePatientsAdult populationPediatric interventionsPositive outcomesOptimal timingHemicraniectomyReasonable outcomesOutcomesStrokeCurrent literature